Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Enzolytics Inc
(OP:
ENZC
)
0.0029
+0.0001 (+3.57%)
Streaming Delayed Price
Updated: 3:17 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,388,334
Open
0.0028
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0028
Today's Range
0.0026 - 0.0029
52wk Range
0.0014 - 0.0603
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Final Report From the National Centre of Infectious and Parasitic Diseases Concludes Lyophilized Pepsin Significantly Reduces the Survival and Proliferation of Growth in Specific Cancer Cells
August 20, 2024
Via
ACCESSWIRE
Penny Stocks to Watch August 2024: SPZI, RJDG, HIRU, AABB more inside…
August 02, 2024
Via
AB Newswire
Performance
YTD
-85.05%
-85.05%
1 Month
+52.63%
+52.63%
3 Month
-29.27%
-29.27%
6 Month
-82.53%
-82.53%
1 Year
-93.26%
-93.26%
More News
Read More
Enzolytics, Inc. and the Bulgarian Academy of Sciences Initiate a Cooperative Program Primarily Focusing on Applied and Strategic Research in Immunology for Cancer and HIV/AIDS Applications
July 31, 2024
Via
ACCESSWIRE
Enzolytics, Inc. Enters Into Collaboration Agreement With Manufacturer Elimus Ltd.
July 29, 2024
Via
ACCESSWIRE
Enzolytics Inc. Supports Sagaliam Acquisition Corp Response to Competitors False and Misleading Press Release
July 26, 2024
Via
ACCESSWIRE
Enzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer Treatment
July 01, 2024
Via
ACCESSWIRE
Enzolytics, Inc. Announces Letter of Intent for Exclusive Licensing Agreement for Patented Nitric Oxide Formulation
May 22, 2024
Via
ACCESSWIRE
Enzolytics Inc. Announces Dismissal of The Dimitar Savov Lawsuit in Nevada
April 23, 2024
Via
ACCESSWIRE
Update on Formulation of New Business Strategy
April 12, 2024
Via
ACCESSWIRE
Enzolytics, Inc. Poised to Invest Alongside Sagaliam Acquisition Corp in Revolutionary Room Temperature SPAD Technology
June 03, 2024
Via
ACCESSWIRE
Spotlight: Stocks Under One Penny Key Updates SPZI, HNRC, ENZC, HALB, BIEI
May 23, 2024
Via
AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
Enzolytics, Inc. Announces Formation of Marketing Company in Partnership with Third Coast Fulfillment
May 02, 2024
Via
ACCESSWIRE
Stocks Under 5¢ To Watch Now! HNRC, HALB, ENZC, SNNC, SPZI
February 29, 2024
Via
AB Newswire
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Economy
OTC Stocks to Watch in February: CLNV, HNRC, ENZC, GEVI, PBIO
February 06, 2024
Via
AB Newswire
Topics
Artificial Intelligence
Bonds
Exposures
Artificial Intelligence
Debt Markets
Enzolytics Announces the Signing of the Business Combination Agreement with Sagaliam Acquisition Corp (SAGA)
September 18, 2023
Via
ACCESSWIRE
Patient Population for the Clinical Trials of ITV-1 has been Established by the European Medicines Agency ("EMA")
September 06, 2023
Via
ACCESSWIRE
Virogentics, Inc. Receives Permit for Export to Africa of the ITV-1 Immunotherapy Solidifying the Scheduled Administration of the Treatment
August 08, 2023
Via
ACCESSWIRE
“Exploring Market Opportunities Stocks to Watch Under 5¢ Now: CLNV, ENZC, HNRC, HALB, SPZI”
January 25, 2024
Via
AB Newswire
Topics
Artificial Intelligence
Energy
Exposures
Artificial Intelligence
Fossil Fuels
Enzolytics, Inc. Announces Partnership With the Khalpey AI Lab To Forge the Future of Multi-Organ Remodeling and Rejuvenation With a Strategic Focus on Longevity
January 16, 2024
Via
ACCESSWIRE
Penny Stocks, Shifts in Trends, Notable Performances, and Strategic Developments, Opportunities: CLNV, HALB, SPZI, HNRC, ENZC
January 09, 2024
Via
AB Newswire
Topics
Bonds
Economy
Exposures
Debt Markets
Economy
Enzolytics, Inc. Files Amended December 31, 2022 OTC Report with Audited Financials and Unaudited September 30, 2023 Quarterly Disclosure
November 20, 2023
Via
ACCESSWIRE
Biogenysis, Inc. Announces Partnering with Khalpey AI Lab and Contenta, Ltd. to Incorporate AI in Microbiome Analysis to Identify Biomarkers for Use in Accurately Predicting Alzheimer's Disease Onset and Prevention.
September 05, 2023
Via
ACCESSWIRE
Virogentics, Inc. Provides Update on African Project, European Medicine Agency Application and Clinical Trials for Application for Type 2 Diabetes
August 04, 2023
Via
ACCESSWIRE
CORRECTION FROM SOURCE: Virogentics Announces Approval of Final Protocol from the Dept for HIV and AIDS, Ministry of Health of the DRC
July 24, 2023
Via
ACCESSWIRE
Biogenysis’ International Patent Application, Covering Its Anti-SARS-CoV-2 Monoclonal Antibodies, Advances to Prosecution in Europe and as a U.S. National Stage Application.
August 24, 2023
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.